Downloads: 6
Review Papers | Medical Science | Volume 11 Issue 2, February 2022 | Pages: 889 - 889 | India
BNT162b2 mRNA COVID-19 Vaccine to Fight COVID
Abstract: In this article they worked on the safety and efficacy of BNT162b2 mRNA COVID-19 vaccine. This is an mRNA vaccine which codes for SARS-COVID-2 spike protein. The main objective of their study was to have a check on the safety of the vaccine as well as to find out how far it is effective to prevent COVID-19 spread.
Keywords: BNT162b2, Safety and efficacy, COVID-19 vaccine
How to Cite?: Vaishna Das K. S., "BNT162b2 mRNA COVID-19 Vaccine to Fight COVID", Volume 11 Issue 2, February 2022, International Journal of Science and Research (IJSR), Pages: 889-889, https://www.ijsr.net/getabstract.php?paperid=SR22220102949, DOI: https://dx.doi.org/10.21275/SR22220102949